CAJ | 학술논문

目的：探讨重组人干扰素α-2 b凝胶治疗慢性宫颈炎的临床疗效。方法随机将120例慢性宫颈炎患者分为对照组（凝胶基质）和观察组（重组人干扰素α-2b凝胶），对两组临床疗效、临床病理特征改善情况及不良反应，进行观察和比较。结果与对照组相比，观察组治疗总有效率明显升高，临床病理特征治疗有效率明显升高， P＜0.05。治疗期间，没有出现明显不良反应。结论重组人干扰素α-2b凝胶治疗慢性宫颈炎的疗效显著，安全性高，值得临床推广。
목적：탐토중조인간우소α-2 b응효치료만성궁경염적림상료효。방법수궤장120례만성궁경염환자분위대조조（응효기질）화관찰조（중조인간우소α-2b응효），대량조림상료효、림상병리특정개선정황급불량반응，진행관찰화비교。결과여대조조상비，관찰조치료총유효솔명현승고，림상병리특정치료유효솔명현승고， P＜0.05。치료기간，몰유출현명현불량반응。결론중조인간우소α-2b응효치료만성궁경염적료효현저，안전성고，치득림상추엄。
Objective To study clinical efficacy of recombinant human interferon α-2b gel treatment for chronic cervicitis .Methods 120 cases of chronic cervicitis were randomized into control group ( gel matrix) and observation group ( recombinant human interferon α-2b gel).The clinical efficacy, clinical pathological features improvement and adverse reactions in two groups were observed and compared . Results Compared with control group , the total effective rate significantly increased .The effective treatment rate of the clinical pathologi-cal features was obviously increased in observation group with no obvious adverse reaction , P<0.05.Conclusion The recombinant human interferon α-2b gel treatment for chronic cervicitis has significant efficacy and high safety and is worthy of clinical promotion .